Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             232 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Author index 2012
 22 S1 p. S89-S94
6 p.
 artikel
2 Editorial Board 2012
 22 S1 p. i-
1 p.
 artikel
3 OL Posttranscriptional regulation of the insulin and IGF system Gorospe, M.
 2012
 22 S1 p. S1-
1 p.
 artikel
4 OR09-4 Analysis of growth hormone, prolactin, and insulin/insulin-like growth factor receptors and ligands in the national cancer institute's 60 cell-line panel covering 9 types of human cancer Gosney, E.S.
 2012
 22 S1 p. S24-S25
2 p.
 artikel
5 OR03-2 Anovel GH1 mutation resulting in deletion of amino acids 188–190 is associated with retarded growth Junnila, R.K.
 2012
 22 S1 p. S7-
1 p.
 artikel
6 OR10-4 A novel mutation (p.D1105E) of IGF1R detected in a family of short stature has dominant negative effect to IGF1R, not to IR Kawashima, Y.
 2012
 22 S1 p. S27-
1 p.
 artikel
7 OR07-5 An overview of the GH-2004 project: Catching the growth hormone cheats Holt, R.I.
 2012
 22 S1 p. S19-
1 p.
 artikel
8 OR02-6 AP-1 complex regulates intracellular localization of insulin receptor substrate-1 required for insulin-like growth factor-I-dependent proliferation Yoneyama, Y.
 2012
 22 S1 p. S5-S6
2 p.
 artikel
9 OR03-5 A phase 2, multicenter, multiple-dose, open-label, parallel-group, active controlled, safety, tolerability, pharmacokinetic and pharmacodynamic study of ACP-001 in adult patients with Growth Hormone Deficiency (AGHD) Höybye, C.
 2012
 22 S1 p. S8-S9
2 p.
 artikel
10 OR05-6 Association of SNP rs11107116 in the vicinity of the suppressor of cytokine signaling 2 (SOCS2) gene with serum IGF-I levels during GH replacement therapy in GHD adults Glad, C.A.M.
 2012
 22 S1 p. S14-S15
2 p.
 artikel
11 OR10-1 Bioactive IGF-I and IGFBP-1 in Danish children and adolescents 3 to 5 years after onset of type 1 diabetes. Effect of residual β-cell function Frystyk, J.
 2012
 22 S1 p. S25-S26
2 p.
 artikel
12 OR11-1 Biochemical characterisation of insulin-like growth factor II isoforms associated with tumorigenesis Greenall, S.A.
 2012
 22 S1 p. S28-S29
2 p.
 artikel
13 OR07-6 Biochemical markers of IGF-I misuse: The response of IGF-I and procollagen type III amino-terminal propeptide (P-III-NP) to the administration of recombinant human IGF-I/IGF binding protein-3 in recreational athletes Guha, N.
 2012
 22 S1 p. S20-
1 p.
 artikel
14 OR08-4 Cardioprotection by low-dose IGF-1 in myocardial infarct Kelly, G.M.
 2012
 22 S1 p. S21-S22
2 p.
 artikel
15 OR05-1 Cardiovascular risk status in childhood cancer survivors with treated vs. untreated growth hormone deficiency Petryk, A.
 2012
 22 S1 p. S12-S13
2 p.
 artikel
16 OR07-1 Circulating RNAs as markers of growth hormone doping Kelly, B.N.
 2012
 22 S1 p. S18-
1 p.
 artikel
17 OR03-1 Development of a platform technology to generate long-acting protein therapeutics Wilkinson, I.R.
 2012
 22 S1 p. S6-S7
2 p.
 artikel
18 OR08-5 Diacylglycerol kinase ζ, a novel binding partner of insulin receptor substrate, negatively modulated GLUT4 translocation in 3T3-L1 adipocytes Hakuno, F.
 2012
 22 S1 p. S22-
1 p.
 artikel
19 OR04-1 Dissection of growth and aging by IGFBP-2 variants: Functional analysis of the Arg-Gly-Asp sequence from IGFBP-2 in transgenic mice Zeissler, A.
 2012
 22 S1 p. S9-S10
2 p.
 artikel
20 OR01-1 Early postnatal nutrition programs the somatotropic axis through epigenetic mechanism Kappeler, L.
 2012
 22 S1 p. S1-S2
2 p.
 artikel
21 OR10-2 Effects of raloxifene and estrogen on bioactive IGF-I in healthy and GH-deficient women Birzniece, V.
 2012
 22 S1 p. S26-
1 p.
 artikel
22 OR04-4 Endogenous insulin-like growth factor binding protein 3 (IGFBP-3) contributes to DNA damage-induced apoptosis in breast cancer cells Marzec, K.A.
 2012
 22 S1 p. S10-S11
2 p.
 artikel
23 OR05-3 Examining the impact of growth hormone on the collagen content of adipose tissue Householder, L.A.
 2012
 22 S1 p. S13-S14
2 p.
 artikel
24 OR02-1 First crystal structure of insulin bound to its primary binding site on the insulin receptor Lawrence, M.
 2012
 22 S1 p. S4-
1 p.
 artikel
25 OR03-4 Five months treatment with a long-acting GHRH analog improves cognition in healthy older men and women and in patients with mild cognitive impairment Merriam, G.R.
 2012
 22 S1 p. S8-
1 p.
 artikel
26 OR05-5 Growth hormone-induced insulin resistance involves reduced pyruvat dehydrogenase activity in skeletal muscle Nellemann, B.
 2012
 22 S1 p. S14-
1 p.
 artikel
27 OR09-3 Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression Minoia, M.
 2012
 22 S1 p. S24-
1 p.
 artikel
28 OR11-2 Growth Hormone regulates the circulating levels of the mitochondria-derived peptide humanin Lee, C.
 2012
 22 S1 p. S29-
1 p.
 artikel
29 OR08-3 Hepatic IGF-I production is regulated by Kupffer cells Ishikawa, M.
 2012
 22 S1 p. S21-
1 p.
 artikel
30 OR04-6 IGFBP-3 enhances autophagy to promote breast cancer cell survival during stress Firth, S.M.
 2012
 22 S1 p. S11-
1 p.
 artikel
31 OR11-5 IGFBP-2 is a predictor of longitudinal cardiovascular trends in type 2 diabetes Narayanan, R.P.
 2012
 22 S1 p. S30-
1 p.
 artikel
32 OR11-3 IGF-II and neurogenesis: in vitro and in vivo analyses Ziegler, A.N.
 2012
 22 S1 p. S29-
1 p.
 artikel
33 OR10-6 IGF-I increases glucose utilization during euglycemic clamps in adolescents with type 1 diabetes mellitus Ekström, K.E.I.
 2012
 22 S1 p. S27-S28
2 p.
 artikel
34 OR08-2 IGF-I prevents the development of hepatic fibrosis in nonalcoholic steatohepatitis via regulating oxidative stress and inactivating the hepatic stellate cells Nishizawa, H.
 2012
 22 S1 p. S20-S21
2 p.
 artikel
35 OR06-3 IGF regulation of miR-483–3p expression in the developing human placenta Forbes, K.
 2012
 22 S1 p. S16-
1 p.
 artikel
36 OR04-3 Impact of anti-inflammatory actions of IGFBP-3 in asthma and metabolic syndrome Oh, Y.
 2012
 22 S1 p. S10-
1 p.
 artikel
37 OR09-2 Impact of pre-analytical conditions on measured concentrations of compounds of the GH/IGF-system in rats Popp, S.
 2012
 22 S1 p. S23-S24
2 p.
 artikel
38 OR01-2 Increased GH signalling independent of IGF-1 is associated with increased bone strength in the SOCS2 knockout mouse Dobie, R.
 2012
 22 S1 p. S2-
1 p.
 artikel
39 OR02-5 Insulin and insulin-like growth factor II differentially regulate endocytic sorting and stability of the insulin receptor isoform A Morrione, A.
 2012
 22 S1 p. S5-
1 p.
 artikel
40 OR02-2 Insulin receptor (InsR) and insulin-like growth factor-I receptor (IGF-GR) translocate to nucleus and regulate IGF-GR gene expression in breast cancer cells Sarfstein, R.
 2012
 22 S1 p. S4-
1 p.
 artikel
41 OR02-3 Insulin receptor substrates (IRSs), interacting with Ras-GAP SH3-domain-binding protein 1 (G3BP1), regulate cap-independent translation of bcl-2 mRNA Ozoe, A.
 2012
 22 S1 p. S4-S5
2 p.
 artikel
42 OR03-6 Intranasal administration of Human Growth Hormone (CP024) and induction of IGF-1 in healthy volunteers Jordan, F.
 2012
 22 S1 p. S9-
1 p.
 artikel
43 OR06-6 IRS2-deficient mice show sensorineural hearing loss that is delayed by concomitant PTP1B loss of function Varela-Nieto, I.
 2012
 22 S1 p. S17-
1 p.
 artikel
44 OR11-6 Long-term mortality in patients with isolated GHD, ISS, and SGA treated with recombinant GH during childhood in Sweden: Application of a mortality model developed from the general population Wikland, K. Albertsson
 2012
 22 S1 p. S30-S31
2 p.
 artikel
45 OR08-6 Long-term treatment with TNF-α represses GKAP42 binding to IRS-1 causing impairment of insulin signaling through IRS-1 and insulin-dependent glucose uptake in 3T3-L1 adipocytes Ando, Y.
 2012
 22 S1 p. S22-
1 p.
 artikel
46 OR10-3 Low circulating levels of Insulin-Like Growth factor-I (IGF-I) are associated with a reduced beta-cell function and disposition index in healthy adult males Thankamony, A.
 2012
 22 S1 p. S26-
1 p.
 artikel
47 OR07-3 Measurement of serum IGF-1 by LC-MS-MS: A multi-site validation study for anti-doping testing Bowers, L.D.
 2012
 22 S1 p. S18-S19
2 p.
 artikel
48 OR06-2 Overexpression of microRNA 145 reveals a role for maternal IGF1R in mediating embryo-epithelial juxtacrine communication at implantation Kang, Y.-J.
 2012
 22 S1 p. S15-S16
2 p.
 artikel
49 OR01-3 Pathophysiology of renal calcium handling in acromegaly: What lies behind hypercalciuria? Kamenicky, P.
 2012
 22 S1 p. S2-
1 p.
 artikel
50 OR10-5 Phase I study of figitumumab and pegvisomant in patients with advanced solid tumors Haluska, P.
 2012
 22 S1 p. S27-
1 p.
 artikel
51 OR02-4 Phosphatidylinositol 3-kinase-binding protein, PI3KAP/XB130 crosslinks actin filaments and regulates cell migration Yamanaka, D.
 2012
 22 S1 p. S5-
1 p.
 artikel
52 OR06-1 Physiological low-oxygen tension mediates the Insulin-Like Growth Factor (IGFs) induced signal transduction in Placental Mesenchymal Stem Cell (PMSC) towards enhanced multipotency via polycomb group proteins Youssef, A.
 2012
 22 S1 p. S15-
1 p.
 artikel
53 OR09-6 Placental growth hormone (GHV) is the predominant growth hormone transcript in MCF7 breast cancer cells Herpy, J.
 2012
 22 S1 p. S25-
1 p.
 artikel
54 OR05-4 Positive association of serum prolactin concentrations with all-cause and cardiovascular mortality: Results from a 10-year follow-up of the Study of Health Pomerania (SHIP) Haring, R.
 2012
 22 S1 p. S14-
1 p.
 artikel
55 OR05-2 Pregnancies and live births in a large cohort of patients on growth hormone replacement therapy Vila, G.
 2012
 22 S1 p. S13-
1 p.
 artikel
56 OR01-5 Prevalence of AIP gene mutations in young patients with acromegaly Schöfl, C.
 2012
 22 S1 p. S3-
1 p.
 artikel
57 OR11-4 Prevalence of posttraumatic growth hormone deficiency is highly dependent on the diagnostic set-up – results from The Danish National study on posttraumatic hypopituitarism Klose, M.
 2012
 22 S1 p. S29-S30
2 p.
 artikel
58 OR04-5 Prohibitin-2 is a binding protein for IGFBP-6 on rhabdomyosarcoma cell membranes and modulates IGFBP-6-dependent migration Bach, L.
 2012
 22 S1 p. S11-
1 p.
 artikel
59 OR07-4 Regulation of fuel metabolism during acute exercise in hypopituitarism with growth hormone-deficiency (GHD) Christ, E.
 2012
 22 S1 p. S19-
1 p.
 artikel
60 OR01-6 Regulation of pituitary growth hormone synthesis by sirtuin 1 Theodoropoulou, M.
 2012
 22 S1 p. S3-
1 p.
 artikel
61 OR06-5 Rescue of the age-dependent decline in cerebral glucose uptake by PEGylated IGF-I treatment in a non-human primate Metzger, F.
 2012
 22 S1 p. S16-
1 p.
 artikel
62 OR06-4 Serum insulin-like growth factor (IGF)-1 is insufficient to restore body size in the absence of growth hormone receptor Wu, Y.
 2012
 22 S1 p. S16-
1 p.
 artikel
63 OR08-1 Short-term treatment of old-aged recipient rats with recombinant human growth hormone (rhGH) improves liver repopulation by transplanted hepatocytes Stock, P.
 2012
 22 S1 p. S20-
1 p.
 artikel
64 OR09-5 Signal tranducer and activator of transcription 5 mediates the anti-obesity actions of growth hormone Nelson, C.N.
 2012
 22 S1 p. S25-
1 p.
 artikel
65 OR07-2 Simultaneous stimulation of human 20 kDa growth hormone and 22 kDa growth hormone secretion by ghrelin Tong, J.
 2012
 22 S1 p. S18-
1 p.
 artikel
66 OR04-2 Site directed mutagenesis of specific phosphorylation sites in human IGFBP-1 markedly decreases binding affinity for IGF-I and increases IGF-I function Gupta, M.
 2012
 22 S1 p. S10-
1 p.
 artikel
67 OR09-1 The role of zinc binding and the cellular zinc content in regulated growth hormone secretion Petkovic, V.
 2012
 22 S1 p. S23-
1 p.
 artikel
68 OR03-3 Use of an orally active ghrelin mimetic, macimorelin (AEZS-130), as a safe, simple test for adult GH deficiency: Effect of BMI on optimal cutoff Merriam, G.R.
 2012
 22 S1 p. S7-S8
2 p.
 artikel
69 OR01-4 Validation of a novel approach for the detection of acromegaly with automatic face classification using photographs from the internet Schneider, H.J.
 2012
 22 S1 p. S2-S3
2 p.
 artikel
70 P03-5 Activity of a pancreatic β-cell-specific two-chain product of the IGF-II gene: Vesiculin Lee, K.L.
 2012
 22 S1 p. S72-S73
2 p.
 artikel
71 P01-31 A deubiquitinating enzyme, USP7, is associated with insulin receptor substrate (IRS)-2 forming a negative feedback loop in insulin/IGF signaling Yoshihara, H.
 2012
 22 S1 p. S43-
1 p.
 artikel
72 P02-25 Adipokine levels in mice with altered Growth Hormone (GH) action over lifespan: Identifying the links between adiposity, insulin sensitivity and longevity Lubbers, E.R.
 2012
 22 S1 p. S62-
1 p.
 artikel
73 P03-33 Adult mortality and morbidity in childhood-onset growth hormone deficient patients who received pediatric GH treatment – analysis of the Hypopituitary Control and Complications Study (HypoCCS) Mo, D.
 2012
 22 S1 p. S83-
1 p.
 artikel
74 P03-42 Altered social outcomes in patients growing up with a hypothalamic pituitary condition: Data fromthe KIMS database Gleeson, H.
 2012
 22 S1 p. S86-S87
2 p.
 artikel
75 P01-21 Analysis of the effects of insulin analogues on proliferation and differentiation in skin keratinocytes Solomon, R.
 2012
 22 S1 p. S39-
1 p.
 artikel
76 P02-26 A network analysis of gene expression through childhood highlights changes related to both age and growth Stevens, A.
 2012
 22 S1 p. S62-S63
2 p.
 artikel
77 P02-50 A new cause of GH deficiency: Mutation in the nuclear encoded mitochondrial isoleucyl tRNA-synthetase (IARS2) in 3 patients with severe short stature, cataracts and peripheral neuropathy Deal, C.
 2012
 22 S1 p. S68-
1 p.
 artikel
78 P03-19 Animal model based on IGF-I: Differences in hepatic gene expression of insulin like growth factor binding proteins and liver deiodinase 1 in late pregnant dairy cows with different total IGF-I plasma concentrations Piechotta, M.
 2012
 22 S1 p. S78-
1 p.
 artikel
79 P02-48 A novel long acting human growth hormone (VRS-317): sustained and dose dependent biological activity in growth hormone deficient adults Bright, G.M.
 2012
 22 S1 p. S67-
1 p.
 artikel
80 P02-40 Anti-IGF1 receptor immunoliposomes: A single formulation combining two anticancer treatments with enhanced therapeutic efficiency Hantel, C.
 2012
 22 S1 p. S57-
1 p.
 artikel
81 P02-38 Antitumor activity of Pasireotide (SOM230) alone and in combination with Everolimus (RAD001) in DU-145 human prostate cancer model Schmid, H.A.
 2012
 22 S1 p. S56-S57
2 p.
 artikel
82 P01-4 Antitumor effect of ridaforolimus (MK-8669) in combination with dalotuzumab (MK-0646) and aromatase inhibitor letrozole in a postmenopausal breast cancer model Hou, X.
 2012
 22 S1 p. S34-
1 p.
 artikel
83 P03-20 A proteomics approach to characterising insulin receptor phosphorylation In response to metabolic and mitogenic ligands McCarthy, P.
 2012
 22 S1 p. S78-
1 p.
 artikel
84 P02-32 Ascites from women with ovarian carcinoma contains an elevated in vitro IGF-bioactivity as compared with serum Thomsen, J.
 2012
 22 S1 p. S54-
1 p.
 artikel
85 P03-29 Association of change in insulin-like growth factor (IGF)-I and IGF-binding protein 3 after 1 month of growth hormone (GH) therapy with genetic markers and long-term growth on GH in children with GH deficiency or Turner's syndrome Clayton, P.
 2012
 22 S1 p. S81-
1 p.
 artikel
86 P02-7 Associations of the DHEAs and IGF with cognitive and mental health parameters in the KORA age population: An epidemiologic perspective on neuroendocrine mechanisms Emeny, R.T.
 2012
 22 S1 p. S51-
1 p.
 artikel
87 P02-19 Auxology, GH-IGF-I status and response to rhGH in 3-M syndrome Hanson, D.
 2012
 22 S1 p. S60-
1 p.
 artikel
88 P02-9 Better first year HbA1c in type 1 diabetes mellitus adolescents on long acting insulin analogs vs. NPH insulin is not associated with reversal of their IGF-I deficiency Salemyr, J.
 2012
 22 S1 p. S51-S52
2 p.
 artikel
89 P02-42 Bioavailability of Pegvisomant 30mg/mL formulation compared to 15mg/mL Formulation: Pharmacokinetics, safety, and tolerability in healthy subjects Jen, J.
 2012
 22 S1 p. S65-
1 p.
 artikel
90 P01-40 BMI and sex have major impact on GH peak levels during the GHRH-Arginine test – establishment of normative data applying a newly developed immunoassay Petersenn, S.
 2012
 22 S1 p. S46-
1 p.
 artikel
91 P01-9 BMS-754807 and metformin synergistically inhibit breast and ovarian cancer cell proliferation Becker, M.A.
 2012
 22 S1 p. S35-S36
2 p.
 artikel
92 P02-27 Challenges encountered in the development of an in vivo mouse model system for testing growth hormone antagonist molecules Bielohuby, M.
 2012
 22 S1 p. S63-
1 p.
 artikel
93 P02-36 Circulating levels of IGF-binding proteins in GH transgenic and GH receptor -/- mice Funk, K.R.
 2012
 22 S1 p. S56-
1 p.
 artikel
94 P01-41 Clinical features of Hypophysitis Muraoka, T.
 2012
 22 S1 p. S46-S47
2 p.
 artikel
95 P03-40 Comparison of intuitiveness, ease of use and preference in five growth hormone injection devices Kappelgaard, A.-M.
 2012
 22 S1 p. S86-
1 p.
 artikel
96 P03-16 Correlations of adiponectin with IGFBP-1 in Swedish men with and without type 2 diabetes Gu, H.F.
 2012
 22 S1 p. S77-
1 p.
 artikel
97 P03-39 Cross-sectional studies are prone to selection bias; example from the Danish national study on posttraumatic hypopituitarism Klose, M.
 2012
 22 S1 p. S85-
1 p.
 artikel
98 P02-21 Development of a new growth hormone receptor antagonist Götsch, F.
 2012
 22 S1 p. S61-
1 p.
 artikel
99 P02-56 Development of methods for the sensitive measurement of pulsatile growth hormone in mice Le Tissier, P.
 2012
 22 S1 p. S70-S71
2 p.
 artikel
100 P02-23 Differential effects of GH versus IGF-1 during obesity List, E.O.
 2012
 22 S1 p. S61-
1 p.
 artikel
101 P01-3 Discoidin domain receptor 1 is a new mediator of insulin receptor in breast cancer cells Morcavallo, A.
 2012
 22 S1 p. S33-S34
2 p.
 artikel
102 P02-46 Diurnal variation in the pharmacokinetics of growth hormone administered as a continuous subcutaneous infusion in GH-deficient subjects Janukonyte, J.
 2012
 22 S1 p. S66-
1 p.
 artikel
103 P03-34 Dose-dependent response of Δ insulin-like growth factor I and Δ height to long-term growth hormone therapy in short Japanese children born small for gestational age Horikawa, R.
 2012
 22 S1 p. S83-S84
2 p.
 artikel
104 P01-37 Dose sparing effect of an IGF-I-based dosing regimen in short children treated with Growth Hormone in a 2-Year randomized controlled trial: Therapeutic and pharmacoeconomic considerations Cohen, P.
 2012
 22 S1 p. S45-
1 p.
 artikel
105 P02-31 Effect of different treatments on production of recombinant human growth hormone in CHO cells Zarkesh-Esfahani, S.H.
 2012
 22 S1 p. S64-
1 p.
 artikel
106 P01-46 Effect of short term Growth Hormone (GH) replacement on whole body bone mineral measures of children with Growth Hormone Deficiency (GHD) Khadgawat, R.
 2012
 22 S1 p. S48-
1 p.
 artikel
107 P01-15 Effect of short-term treatment with insulin on decreased IGF-I expression and increased liver triglycerides during protein deprivation Ozaki, Y.
 2012
 22 S1 p. S37-
1 p.
 artikel
108 P01-23 Effects of IGFBP-1 and IGFBP-2 fragments on migration and IGF-induced proliferation of human dermal fibroblasts Brandt, K.
 2012
 22 S1 p. S39-S40
2 p.
 artikel
109 P03-23 Effects of targeting p53/Mdm2/IGF-1R axis on skin melanoma migration, invasion and metastasis Worrall, C.
 2012
 22 S1 p. S79-
1 p.
 artikel
110 P01-47 Effects of 10 years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset Svensson, J.
 2012
 22 S1 p. S48-S49
2 p.
 artikel
111 P01-17 Elevated serum IGF-I concentrations and accelerated aging in long-term growth selected mouse lines Langhammer, M.
 2012
 22 S1 p. S37-S38
2 p.
 artikel
112 P03-35 Elucidation of mechanism underlying growth retardation caused by human growth hormone mutant E74K Kircheva, Z.I.
 2012
 22 S1 p. S84-
1 p.
 artikel
113 P03-10 Epigenetic reprogramming of IGFBP-2 in prostate cancer mediates hyperglycaemia-induced chemoresistance and the effect of metformin Biernacka, K.
 2012
 22 S1 p. S74-
1 p.
 artikel
114 P02-30 Estrogen regulates exercise-induced pituitary type 1 deiodinase increase and growth hormone secretion Ignacio, D.L.
 2012
 22 S1 p. S64-
1 p.
 artikel
115 P01-7 Evaluation of the biological actions of insulin analogues in endometrial cancer cell lines Aizen, D. Balas
 2012
 22 S1 p. S35-
1 p.
 artikel
116 P03-43 Evolving growth hormone deficiency in patients previously thought to have idiopathic short stature Regelmann, M.O.
 2012
 22 S1 p. S87-
1 p.
 artikel
117 P01-27 Expression of IGF2 and IGF1R in pediatric adrenocortical tumors (ACT): Overexpression of IGF1R is associated with unfavorable event and metastasis in adrenocortical carcinomas Lira, R.C.P.
 2012
 22 S1 p. S41-
1 p.
 artikel
118 P03-31 Factors affecting IGF-I response to Growth Hormone (GH) replacement therapy during transition in patients with childhood-onset GH deficiency Thankamony, A.
 2012
 22 S1 p. S82-
1 p.
 artikel
119 P01-49 Familial acromegaly and familial prolactinoma cases in Hungary Déenes, J.
 2012
 22 S1 p. S49-
1 p.
 artikel
120 P01-6 Fenofibrate-mediated inhibition of IGF-I receptor signaling responses and its contribution to anticancer treatment Reiss, K.
 2012
 22 S1 p. S34-S35
2 p.
 artikel
121 P02-47 First interim results from an international phase IV study in short children born small for gestational age (SGA) treated with Omnitrope® (rhGH) Schwarz, H.-P.
 2012
 22 S1 p. S67-
1 p.
 artikel
122 P03-12 Functional dysregulation of immune responses in a Balb/c model deficient in circulating IGF-I due to protein malnutrition and infected with Leishmania (Leishmania) infantum Cuervo-Escobar, S.
 2012
 22 S1 p. S75-
1 p.
 artikel
123 P01-22 Genome-wide analysis of cancer protection pathways in Laron Syndrome patients Lapkina, L.
 2012
 22 S1 p. S39-
1 p.
 artikel
124 P02-24 GH deficiency does not account for metabolic changes in adult patients with craniopharyngioma Roemmler, J.
 2012
 22 S1 p. S62-
1 p.
 artikel
125 P02-45 Ghrelin and growth hormone levels are decreased in Saudi autistic children Al-Zaid, F.
 2012
 22 S1 p. S66-
1 p.
 artikel
126 P03-45 GH retesting and lipid profile in childhood-onset GHD when reaching final adult height Wacharasindhu, S.
 2012
 22 S1 p. S88-
1 p.
 artikel
127 P02-28 Growth hormone analogues with protracted effect through pegylation or non-covalent albumin binding Thygesen, P.
 2012
 22 S1 p. S63-
1 p.
 artikel
128 P02-53 Growth Hormone: a potential biomarker for disease progression in Amyotrophic Lateral Sclerosis (ALS) Ngo, S.T.
 2012
 22 S1 p. S69-S70
2 p.
 artikel
129 P03-30 Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndrome Höybye, C.
 2012
 22 S1 p. S82-
1 p.
 artikel
130 P03-32 Height outcome in late diagnosed growth hormone (GH) deficiency type II with GH-1 gene mutation (GH-R178H) affecting secretion and action: Use of higher than standard dose GH and pubertal suppression to optimise final height Buchanan, C.R.
 2012
 22 S1 p. S82-S83
2 p.
 artikel
131 P03-22 High glucose enhanced the inhibitory effect of mast cell chymase on the IGF-I-stimulated proliferation of rat aortic smooth muscle cells Wang, J.
 2012
 22 S1 p. S79-
1 p.
 artikel
132 P03-7 Hyperglycaemia, IGFs and insulin affect alternative splicing of the insulin receptor in DU145 prostate cancer cells Wang, J.
 2012
 22 S1 p. S73-
1 p.
 artikel
133 P03-15 Hyperglycemia confers resistance to antibodies targeting growth factor receptors on breast cancer cells Zeng, L.
 2012
 22 S1 p. S76-
1 p.
 artikel
134 P01-35 Identification of BRCA1 as a biomarker for IGF-GR targeted therapy in breast cancer Cohen-Sinai, T.
 2012
 22 S1 p. S44-
1 p.
 artikel
135 P01-20 Identification of microRNAs involved in regulating IGF signalling in the first trimester placenta Farrokhnia, F.
 2012
 22 S1 p. S38-S39
2 p.
 artikel
136 P01-18 IGFBP-2 acts as a survival factor for breast cancer cells: Role of ER-α Zeng, L.
 2012
 22 S1 p. S38-
1 p.
 artikel
137 P03-24 IGFBP-2 is a novel regulator of the estrogen receptor in breast epithelial cells Zeng, L.
 2012
 22 S1 p. S80-
1 p.
 artikel
138 P01-28 IGF-1-cGP axis and its role in maintaining homeostasis IGF-1 bioactivity Guan, J.
 2012
 22 S1 p. S41-S42
2 p.
 artikel
139 P01-11 IGF-I acts as a potent chemotactic factor for spleen lymphocytes Escobar, S.A. Cuervo
 2012
 22 S1 p. S36-
1 p.
 artikel
140 P03-21 IGF-I and the resumption of ovarian activity in cows Obese, F.Y.
 2012
 22 S1 p. S78-S79
2 p.
 artikel
141 P02-14 IGF-I as a diagnostic tool in feline medicine: Evaluation of an ELISA Strage, E.
 2012
 22 S1 p. S53-S54
2 p.
 artikel
142 P01-30 IGF-I deficiency predisposes to presbycusis and noise-induced hearing loss in a mice model Murillo-Cuesta, S.
 2012
 22 S1 p. S42-
1 p.
 artikel
143 P01-29 IGF-I-dependent intestinal fibrosis in Crohn's1 disease and TNBS-induced colitis is regulated by αVβ3 integrin Kuemmerle, J.F.
 2012
 22 S1 p. S42-
1 p.
 artikel
144 P02-39 IGF-II analogue improves placental efficiency, modifies placental growth and reduces fetal weight distribution in normal mice Charnock, J.C.
 2012
 22 S1 p. S57-
1 p.
 artikel
145 P03-17 IGF-I on the dark side: Negative consequences of IGF-I on mitochondrial homeostasis Sell, C.
 2012
 22 S1 p. S77-
1 p.
 artikel
146 P01-2 IGF-I treatment unveils cell-context dependent regulation of frataxin Franco, C.
 2012
 22 S1 p. S33-
1 p.
 artikel
147 P01-14 IGF-I: Vitronectin interactions modulate changes in expression of genes which induce breast cancer cell survival and migration Kashyap, A.S.
 2012
 22 S1 p. S36-S37
2 p.
 artikel
148 P01-32 IGF-1 mediates embryo-epithelial juxtacrine communication at implantation through the osteopontin-integrin αvβ3 system Kang, Y.-J.
 2012
 22 S1 p. S43-
1 p.
 artikel
149 P01-16 IGF receptor signaling regulates mammary epithelial cell fate and tumor susceptibility Wood, T.L.
 2012
 22 S1 p. S37-
1 p.
 artikel
150 P01-19 IGF-1 signalling enhances mitochondria activity and biogenesis in cancer cells independently of glycolytic switch Favre, C.
 2012
 22 S1 p. S38-
1 p.
 artikel
151 P03-2 In prostate cancer cells metformin inhibits the cross-talk between membrane-initiated androgens and IGF-GR Malaguarnera, R.
 2012
 22 S1 p. S71-
1 p.
 artikel
152 P03-18 Insulin and IGF-I receptors in human cardiac microvascular endothelial cells; metabolic, mitogenic and anti-inflammatory effects Arnqvist, H.J.
 2012
 22 S1 p. S77-
1 p.
 artikel
153 P03-3 Insulin-like growth factor I-deficiency causes skeletal defects that can be partially compensated by parathyroid hormone-related protein in mice Rodíguez-de la Rosa, L.
 2012
 22 S1 p. S72-
1 p.
 artikel
154 P03-26 Insulin-like Growth Factor-II increases de novo steroidogenesis in prostate cancer cells Lubik, A.A.
 2012
 22 S1 p. S80-
1 p.
 artikel
155 P02-10 Insulin sensitizers modulate IGFBP-1 in EMPOWIR (Enhance the Metabolic Profile of Women with Insulin Resistance) – a randomized clinical trial (NCT00618071) of normoglycemic hyperinsulinemic women with midlife weight gain Mogul, H.R.
 2012
 22 S1 p. S52-
1 p.
 artikel
156 P02-33 Intramuscular administration of PEGylated IGF-I accelerates skeletal muscle regeneration after myotoxic injury Metzger, F.
 2012
 22 S1 p. S54-S55
2 p.
 artikel
157 P01-1 Investigating the mechanisms and role of IGFBP-2 nuclear translocation in cancer cells Azar, W.J.
 2012
 22 S1 p. S33-
1 p.
 artikel
158 P03-9 Investigation of the anti-tumorigenic effects of the M6P/IGF-II receptor Scott, C.D.
 2012
 22 S1 p. S74-
1 p.
 artikel
159 P01-25 Ketogenic low-carb/high-fat diets lead to lower IGF-I levels and reduced longitudinal growth in rats regardless of whether the dietary fat source derives from beef tallow or soybean oil Taxeidi, C.
 2012
 22 S1 p. S40-
1 p.
 artikel
160 PL08 Deconstructing muscle differentiation: defining insulin-like growth factor actions in muscle development and repair Rotwein, P.
 2012
 22 S1 p. S17-
1 p.
 artikel
161 PL03 From Galton to GWAS: what we have learned about the genetics of human stature? Visscher, P.M.
 2012
 22 S1 p. S6-
1 p.
 artikel
162 PL12 Growth hormone and IGF-1 in mouse models of growth and metabolism LeRoith, D.
 2012
 22 S1 p. S28-
1 p.
 artikel
163 PL11 Growth hormone: From starvation to obesity Klibanski, A.
 2012
 22 S1 p. S28-
1 p.
 artikel
164 PL06 IGF-II and feto-placental growth Constância, M.
 2012
 22 S1 p. S12-
1 p.
 artikel
165 PL04 IGF-I, obesity and diabetes Bang, P.
 2012
 22 S1 p. S6-
1 p.
 artikel
166 PL02 IGF receptor signalling and regulation in cancer O'Connor, R.
 2012
 22 S1 p. S1-
1 p.
 artikel
167 PL10 Neuroprotection and plasticity in the brain related to GH & IGF-I Aberg, D.
 2012
 22 S1 p. S23-
1 p.
 artikel
168 P02-20 Local overexpression of growth hormone and GH/IGF-1-associated effects in the adult hippocampus Aberg, M.
 2012
 22 S1 p. S60-
1 p.
 artikel
169 P02-49 Long-term outcomes of Pegvisomant (Somavert®) monotherapy: Cross-sectional observations from ACROSTUDY van der Lely, A.J.
 2012
 22 S1 p. S68-
1 p.
 artikel
170 P02-4 Long term treatment of rh-IGF-1 and high dose insulin of a Japanese patient with insulin receptor defect Tajima, T.
 2012
 22 S1 p. S50-
1 p.
 artikel
171 P02-8 Low IGF-1 levels are associated with and predictive for the incidence of anxiety disorders in primary care patients (DETECT-cohort) and the general population (SHIP-cohort) Sievers, C.
 2012
 22 S1 p. S51-
1 p.
 artikel
172 P01-34 Low-intensity pulsed ultrasounds produces and increase of IGF-I gene expression during fibula bone repair in rats Marrero, I.
 2012
 22 S1 p. S44-
1 p.
 artikel
173 PL05 Prolactin and tumorigenesis Goffin, V.
 2012
 22 S1 p. S12-
1 p.
 artikel
174 PL07 The essential role of GH/IGF-I in the liver Takahashi, Y.
 2012
 22 S1 p. S17-
1 p.
 artikel
175 PL01 Two years in GH Ho, K.
 2012
 22 S1 p. S1-
1 p.
 artikel
176 PL09 Two years in IGF Rosenfeld, R.G.
 2012
 22 S1 p. S22-S23
2 p.
 artikel
177 P01-13 Mechanisms behind nuclear translocation of the IGF-1R Sjostrom, S.
 2012
 22 S1 p. S36-
1 p.
 artikel
178 P03-44 MR imaging features of growth hormone-producing pituitary adenoma Fukuda, I.
 2012
 22 S1 p. S87-
1 p.
 artikel
179 P03-41 Natural history of congenital isolated growth hormone deficiency Laron, Z.
 2012
 22 S1 p. S86-
1 p.
 artikel
180 P02-41 Non alcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-1 levels Fusco, A.
 2012
 22 S1 p. S64-S65
2 p.
 artikel
181 P03-37 Once-weekly, CTP-modified hGH (MOD-4023) is effective in growth hormone deficient adults: A phase II, dose and frequency finding study Goth, M.I.
 2012
 22 S1 p. S84-S85
2 p.
 artikel
182 P02-44 Oral octreotide absorption in human subjects: Comparable pharmacokinetics to parenteral octreotide and effective growth hormone suppression Tuvia, S.
 2012
 22 S1 p. S66-
1 p.
 artikel
183 P01-48 Pediatric patients with Prader-Willi syndrome are responders to growth hormone treatment: Analysis of 3-year data from the ANSWER Program Cohen, P.
 2012
 22 S1 p. S49-
1 p.
 artikel
184 P02-18 Pharmacological characterisation of NNC0195–0092, a long-acting growth hormone derivative Thygesen, P.
 2012
 22 S1 p. S59-S60
2 p.
 artikel
185 P03-25 Pharmacological properties of BI 836845, a fully human IGF ligand neutralizing antibody Hofmann, M.H.
 2012
 22 S1 p. S80-
1 p.
 artikel
186 P01-39 Polymorphisms in genes related to lipid metabolism contribute to individual differences in serum lipid profile of growth hormone deficient (GHD) adults Barbosa, E.J.
 2012
 22 S1 p. S46-
1 p.
 artikel
187 P01-38 Post-stroke inflammatory response may influence pituitary function in patients with brain ischemic and hemorrhagic injury Bondanelli, M.
 2012
 22 S1 p. S45-
1 p.
 artikel
188 P03-14 Posttranslational modifications of the insulin-like growth factor-binding protein 3 in patients with non-insulin dependent diabetes mellitus and their effect on ligand binding Nedic, O.
 2012
 22 S1 p. S76-
1 p.
 artikel
189 P03-13 Preclinical effectiveness of metformin in Ewing sarcoma Garofalo, C.
 2012
 22 S1 p. S75-S76
2 p.
 artikel
190 P02-54 Prediabetes in adult growth hormone deficiency is associated with a substantial reduction in serum and adipose tissue expression levels of zinc-α2-glycoprotein Balaz, M.
 2012
 22 S1 p. S70-
1 p.
 artikel
191 P01-33 Proinsulin may exert biological effects in MCF-7 human cancer cells through both isoform A of the insulin receptor and atypical IGF-I receptors Malaguarnera, R.
 2012
 22 S1 p. S43-S44
2 p.
 artikel
192 P02-3 Prolactinomas in two patients with pituitary developmental gene mutations Doknic, M.
 2012
 22 S1 p. S58-S59
2 p.
 artikel
193 P02-29 Quantification of brown adipocyte markers in white adipose tissues of mice with altered Growth Hormone action Vesel, C.B.
 2012
 22 S1 p. S63-S64
2 p.
 artikel
194 P03-11 Quantifying insulin receptor isoform expression in FFPE breast tumors Harrington, S.
 2012
 22 S1 p. S75-
1 p.
 artikel
195 P01-43 Radiotherapy and growth hormone replacement therapy in growth hormone deficient adults with craniopharyngioma: Preliminary data from the Dutch National Registry of Growth Hormone Treatment in Adults van Varsseveld, N.C.
 2012
 22 S1 p. S47-S48
2 p.
 artikel
196 P02-55 Reduced epiphyseal growth plate GHR signaling in a chronic kidney disease rat model of growth retardation Troib, A.
 2012
 22 S1 p. S70-
1 p.
 artikel
197 P02-11 Regulation of insulin-like growth factor binding protein-6: An inhibitor of fibroblast proliferation and myofibroblast differentiation in Dupuytren's Disease Raykha, C.
 2012
 22 S1 p. S52-
1 p.
 artikel
198 Program at a Glance 2012
 22 S1 p. vi-
1 p.
 artikel
199 P02-34 Role of Igf-1 signaling in statin-induced myotoxicity Bonifacio, A.
 2012
 22 S1 p. S55-
1 p.
 artikel
200 P01-10 Selective recruitment of G protein coupled receptor kinases (GRKs) controls trafficking of Insulin-like Growth Factor-1 Receptor (IGF-1R) Zheng, H.
 2012
 22 S1 p. S36-
1 p.
 artikel
201 P02-6 Serum IGF-I in breast cancer patients – a comparative study of IGF-I measurements by both automated methodology (IDS iSYS) as well as gel chromatography at low pH Espelund, U.
 2012
 22 S1 p. S50-S51
2 p.
 artikel
202 P02-13 Serum IGF-I levels in children with idiopathic short stature (ISS) during treatment with Somatropin in a prospective, longitudinal non-randomised, open, phase II study Dörr, H.G.
 2012
 22 S1 p. S53-
1 p.
 artikel
203 P02-12 Serum insulin-like growth factor binding protein-3 (IGFBP-3) levels are correlated with glycemic control and lipid metabolism in adolescents with type 2 diabetes Lee, D.-Y.
 2012
 22 S1 p. S53-
1 p.
 artikel
204 P02-35 Severe reductions of brain weights and behavioral changes in transgenic mice overexpressing mutated IGFBP-2 lacking a heparin binding domain Schindler, N.
 2012
 22 S1 p. S55-S56
2 p.
 artikel
205 P02-2 Sex-specific associations of serum prolactin concentrations with cardiac remodeling: Longitudinal results from the study of health Pomerania (SHIP) Haring, R.
 2012
 22 S1 p. S58-
1 p.
 artikel
206 P02-17 Sirt1 negatively regulates IGF-I production by growth hormone via deacetylation of Stat5 in liver Yamamoto, M.
 2012
 22 S1 p. S59-
1 p.
 artikel
207 P01-50 Smoking, body composition and bone health in adult patients with Growth Hormone (GH)-treated GH deficiency – an observational study Klefter, O.N.
 2012
 22 S1 p. S49-S50
2 p.
 artikel
208 P02-22 Sodium Butyrate treatment increases Growth Hormone (GH) secretion in autosomal dominant GH deficiency caused by the splice site mutations Miletta, M.C.
 2012
 22 S1 p. S61-
1 p.
 artikel
209 P02-37 Structural and functional alterations in skeletal muscle of IGFBP-4 KO mice Zhao, X.
 2012
 22 S1 p. S56-
1 p.
 artikel
210 P03-6 Structural studies of insulin-like growth factor I interacting with the type 1 Insulin-like growth factor receptor in the presence of inhibiting or enhancing monoclonal anti-bodies Thomas, D.
 2012
 22 S1 p. S73-
1 p.
 artikel
211 P03-28 Structural studies of the type 1 insulin-like growth factor receptor in apo- and ligand-bound forms by cryo-electron microscopy Kong, G.K.W.
 2012
 22 S1 p. S81-
1 p.
 artikel
212 P03-46 Successful pregnancy during use of octreotide and pegvisomant in an acromegalic patient van der Klauw, M.M.
 2012
 22 S1 p. S88-
1 p.
 artikel
213 P03-38 Suppressor of cytokine signaling 2 missense mutation identified in a patient with gigantism without growth hormone producing pituitary adenoma Suda, K.
 2012
 22 S1 p. S85-
1 p.
 artikel
214 P03-36 Sustained effect of Insulin-Like Growth Factor-I (IGF-I)-based dosing of Growth Hormone Treatment (GHT) in children: Comparative analysis of data from a randomized trial and the ANSWER Program® Cohen, P.
 2012
 22 S1 p. S84-
1 p.
 artikel
215 P02-43 Tailored GH treatment in paediatric settings – it is time for a paradigm-shift based on two randomized trials Dahlgren, J.
 2012
 22 S1 p. S65-
1 p.
 artikel
216 P02-5 The association of serum insulin-like growth factor-I with metabolic syndrome in older people: A population-based study van Bunderen, C.C.
 2012
 22 S1 p. S50-
1 p.
 artikel
217 P02-1 The association of serum prolactin concentration with inflammatory biomarkers – cross-sectional findings from the population-based Study of Health in Pomerania Friedrich, N.
 2012
 22 S1 p. S58-
1 p.
 artikel
218 P01-24 The combination of the IGF-1 receptor inhibitor picropodophylin (PPP) and the BH3 mimetic ABT-737 has synergistic anti-myeloma activity Bieghs, L.
 2012
 22 S1 p. S40-
1 p.
 artikel
219 P02-52 The decline in pulsatile growth hormone secretion throughout early adulthood in mice is exacerbated by dietary induced weight gain Huang, L.
 2012
 22 S1 p. S69-
1 p.
 artikel
220 P01-42 The effect of growth hormone replacement therapy (GHRT) on exercise capacity, fat mass, ectopic lipids [intramyocellular (IMCL) and intrahepatocellular lipids (IHCL)] and insulin resistance in hypopituitary patients with growth hormone deficiency (GHD) Christ, E.
 2012
 22 S1 p. S47-
1 p.
 artikel
221 P03-4 The impact of capsaicin-induced sensory denervation on osteogenesis and mRNA expressions of IGF-1, IGF-1R and IGFBP-4 in cortical bone. A study of bone distraction in the osteotomic femur of rat Li, J.
 2012
 22 S1 p. S72-
1 p.
 artikel
222 P03-27 The Insulin-like Growth Factor 1 Receptor displaces PKCs from RACK1 to facilitate migration of cancer cells Kiely, P.
 2012
 22 S1 p. S80-S81
2 p.
 artikel
223 P01-26 The Interactions of Insulin-like Growth Factor-I with transglutaminases – a novel pathway with wide ranging clinical implications Sivaramakrishnan, M.
 2012
 22 S1 p. S40-S41
2 p.
 artikel
224 P02-15 The relation between diabetic children and insulin like growth factor-1 Rasheed, A.O.
 2012
 22 S1 p. S54-
1 p.
 artikel
225 P01-5 The role of insulin-like growth factor binding protein-6 in the differentiation of placental mesenchymal stem cells into skeletal muscle Aboalola, D.
 2012
 22 S1 p. S34-
1 p.
 artikel
226 P02-16 The SOCS2 Ubiquitin ligase complex regulates Growth Hormone Receptor levels Vesterlund, M.
 2012
 22 S1 p. S59-
1 p.
 artikel
227 P01-36 The use of growth hormone and other performance enhancing drugs by university students Hayward, O.
 2012
 22 S1 p. S44-
1 p.
 artikel
228 P03-8 Tumorigenicity of Ewing's sarcoma cells is dependent on the level of beta-arrestin 1 Oprea, I.I.
 2012
 22 S1 p. S73-S74
2 p.
 artikel
229 P01-45 Twenty-four months efficacy and safety of LB03002, a new sustained release formulation of rhGH, in children with GHD: Extension of a phase III randomized multicentre study Saenger, P.
 2012
 22 S1 p. S48-
1 p.
 artikel
230 P03-1 Ubiquitin ligase Nedd4 interacts with Insulin Receptor Substrate (IRS)-2 in response to humoral/nutritional stimuli, thereby enhancing IRS-2-mediated IGF/insulin signals through a novel mechanism Fukushima, T.
 2012
 22 S1 p. S71-
1 p.
 artikel
231 P01-8 Wound healing rate is not impaired in mice with deficiency of liver-derived insulin-like growth factor-I (IGF-I) Botusan, I.R.
 2012
 22 S1 p. S35-
1 p.
 artikel
232 REMOVED: P02-51 Product wastage from modern human growth hormone administration devices: A laboratory analysis Kappelgaard, A.-M.
 2012
 22 S1 p. S68-S69
2 p.
 artikel
                             232 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland